Related Experiment Video
Updated: Jun 12, 2025

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
A new LRRK2 variant in a family with Parkinson's disease affects binding to RAB8A
Lydia Vela-Desojo1, Alba Pascual2,3, Victor Montal4
1Movement Disorders Unit, Department of Neurology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
Abstract:
Pathogenic variants in the LRRK2 gene affecting catalytic domains are the most common genetic cause of Parkinson's disease (PD). Nevertheless, LRRK2 variants at the armadillo (ARM) domain would indirectly affect the protein's activity by interacting with RAB proteins. We present a family with PD recurrence segregating the new LRRK2 allele at the ARM domain, p.[Leu.119Pro;Leu488Pro]. Clinical exams were conducted on nine relatives. Neuropathology of the index case showed loss of substantia nigra neurons and Alzheimer's disease-type lesions. In silico analysis of the p.[Leu.119Pro;Leu488Pro] LRRK2 variant predicted alterations in ARM tertiary structure and binding affinity. These predictions were supported by functional genomics using recombinant LRRK2WT and LRRK2Leu119Pro;Leu488Pro. We found increased interaction between LRRK2Leu119Pro;Leu488Pro and RAB8A, but not with RAB10. Additionally, docking studies revealed stronger affinity of LRRK2Leu119Pro;Leu488Pro for RAB8A (P < 0.0001) and allosteric properties beyond the mutated residues. We propose p.[Leu119Pro;Leu488Pro] as a cause of familial PD.
Insights
A novel LRRK2 gene variant, p.[Leu119Pro;Leu488Pro], located in the ARM domain, is linked to familial Parkinson's disease (PD). This variant alters protein interactions and may cause PD by affecting LRRK2's function.
Area of Science:
- Neurogenetics
- Molecular Biology
- Pathology
Background:
- Pathogenic variants in the Leucine-rich repeat kinase 2 (LRRK2) gene are a common genetic cause of Parkinson's disease (PD).
- LRRK2 variants affecting the armadillo (ARM) domain may indirectly influence protein activity through interactions with RAB proteins.
Purpose of the Study:
- To investigate a novel LRRK2 gene variant, p.[Leu119Pro;Leu488Pro], identified in a family with recurrent Parkinson's disease.
- To elucidate the molecular mechanisms by which this ARM domain variant contributes to PD pathogenesis.
Main Methods:
- Clinical examination of nine family members.
- Neuropathological analysis of the index case.
- In silico analysis, functional genomics with recombinant LRRK2, and molecular docking studies.
Main Results:
- The p.[Leu119Pro;Leu488Pro] variant was identified in a family with PD.
- In silico analysis predicted structural and binding alterations.
- Functional studies showed increased interaction and binding affinity of LRRK2^Leu119Pro;Leu488Pro with RAB8A.
Conclusions:
- The novel LRRK2 variant p.[Leu119Pro;Leu488Pro] is proposed as a cause of familial Parkinson's disease.
- The variant's effects on LRRK2-RAB protein interactions suggest a novel mechanism in PD pathogenesis.
Related Concept Videos
Lysosomal Hydrolases
Neural Regulation
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...

